Q1 2026 Management view CEO Christopher Hall said, “Since we launched NeXT Personal, we haven't just validated our win in MRD strategy, we have disrupted the market,” and framed 2026 as an execution ...
New Lab Volume Index, Highlighting More Trends and Expanded Functionality, Shows Testing Capacity Being Absorbed by Doubling of Demand for Women’s Health, Led by Prenatal Testing New Lab Volume Index, ...
It also lowered expected exome and genome revenue growth to at least 20%, from 33–35%, while maintaining volume growth of at least 30%. ・Stueland added that the company remains confident in its ...
The number of annual colonoscopies performed in the U.S. is projected to decline over the next decade as use of noninvasive ...
SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results